Categories: News

KARL STORZ unifies its US organizations under a central management team, Sonal Matai named US President

Enhanced organizational structure will drive innovation and improve engagement with and delivery of excellence to KARL STORZ customers, accelerating growth




EL SEGUNDO, Calif.–(BUSINESS WIRE)–KARL STORZ, a leading family-owned medical technology company, today announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed. Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.

“The US is the world’s largest medical device market and also the largest market for KARL STORZ,” said Sonal Matai, US President of KARL STORZ. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and superior service.”

“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the US,” Matai added.

Matai was previously Managing Director, KARL STORZ Endoscopy-America, Inc. In that role, he spearheaded a period of significant innovation and market share expansion. His prior leadership experiences at large MedTech companies and start-ups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.

About KARL STORZ

KARL STORZ United States is a leader in endoscopic technology and imaging solutions across virtually all surgical specialties. It is a subsidiary of KARL STORZ SE & Co. KG, an international medical technology company that is family-owned and based in Tuttlingen, Germany. KARL STORZ stands for visionary design, precision craftsmanship, and clinical effectiveness and has a portfolio that includes more than 15,000 products for human and veterinary medicine.

Contacts

MEDIA CONTACT:

Susan Mancia

Director, Integrated Marketing Communications

KARL STORZ United States

Phone: 562-841-1515

Email: susan.mancia@karlstorz.com

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

8 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

8 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago